Canada markets closed

Manitex Capital Inc. (MNX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.92000.0000 (0.00%)
At close: 1:26PM EST

Manitex Capital Inc.

16667 Hymus Boulevard
Kirkland, QC H9H 4R9
514 693 8830

Sector(s)Financial Services
IndustryAsset Management
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven SaviukChairman, Pres & CEO344.07kN/A1959
Ms. Helen SaviukCFO & Director167.5kN/AN/A
Mr. Ronald S. Perry CA, CPASec.N/AN/A1956
Mr. Marc LégerExec. VP of Commercial Operations - Valeo Pharma Inc144.89kN/AN/A
Nathalie TherrienVice-Pres of QA & Regulatory Affairs - Valeo Pharma Inc.135.17kN/AN/A
Mr. Luc Mainville M.B.A., M.B.ASr. VP & CFO of Valeo Pharma Inc135kN/A1964
Mr. Kristof BinieckiVP of Scientific Affairs - Valeo Pharma IncN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Manitex Capital Inc. does not have significant business. It focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies. Previously, it was engaged in the acquisition and markets specialty pharmaceutical products, and distributes third-party pharmaceutical products, as well as holds a portfolio in marketable securities. The company is headquartered in Kirkland, Canada.

Corporate Governance

Manitex Capital Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.